Biomarker Discovery in Human Prostate Cancer Patient Samples

This case study highlights the utility of combining Multidimensional Protein Identification Technology (MuDPIT) and BIOiTRAQ technology for biomarker discovery and relative protein quantitation for samples of human plasma and urine. The overall goal was to investigate plasma and urine samples derived from normal patients as compared to those with early and late stage prostate cancer.